PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsAnaphylaxis
MeSH D000707 - anaphylaxis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006969:Immediate hypersensitivity
0 Companies
0 Drugs
Success rate
D000707: 
Anaphylaxis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaEpinephrine Epinephrine  2018-08-16   
Promethazine Promethazine  2002-08-22   
PadagisPromethazine Promethazine  2003-06-30   
Taro PharmaceuticalPromethazine Promethazine  2006-10-26   
MylanEpinephrine Epi 2025-09-11 1987-12-22   
Promethazine Phenergan  1982-01-01   
Promethazine Promethazine  2002-11-21   
Armstrong PharmaceuticalsEpinephrine Epinephrine  1984-05-23   
Epinephrine Primatene Mist 2026-01-26 2018-11-07   
SandozPromethazine Promethazine  2006-11-08   
AstraZenecaPrilocaine, Epinephrine Citanest  1982-01-01   
Epinephrine, Etidocaine Duranest  1982-01-01   
Lidocaine, Epinephrine Xylocaine W/ Epinephrine  1982-01-01   
WyethEpinephrine Bronitin Mist  1982-01-01   
Promethazine Phenergan  1982-01-01   
Sterling WinthropEpinephrine Bronkaid Mist  1982-01-01   
3MEpinephrine Medihaler-epi  1982-01-01   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
33%
1/3
Phase 2
33%
1/3
Phase 3
100%
3/3
Approved: 3Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
AstraZeneca
1
2
3
4
5
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use